Thromboembolic disease in testicular germ cell tumors—real-world evidence of three Portuguese institutions
TE in TGCT occurred only in patients with advanced disease, was linked to tumor burden and CVC use, and was not predicted by current models. These findings highlight the need for TGCT-specific risk tools and prospective studies on risk-adapted prophylaxis.
Authors
- Jorge C. Correia (ORCID: https://orcid.org/0000-0002-6377-9053)
- José Alberto Teixeira (ORCID: https://orcid.org/0000-0001-9881-2207)
- João Godinho (ORCID: https://orcid.org/0000-0003-2411-3993)
- Inês Margarido (ORCID: https://orcid.org/0009-0004-8716-0804)
- João Rato (ORCID: https://orcid.org/0000-0003-2080-2361)
- Madalena Machete
- Joana Albuquerque (ORCID: https://orcid.org/0000-0003-1989-3526)
- Martim Peixoto de Oliveira
- Rita Bizarro
- Carlota Baptista
- Diana Neto-Silva
- José Luís Passos-Coelho
Institutions
- Universidade Católica Portuguesa (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Hospital da Luz (PT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.3389/fonc.2026.1772608
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00